Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit -- it could help ...

Novo Nordisk (NVO) stock took a hit this week, after a Super Bowl ad highlighted a growing challenge to the company’s ...

Telehealth stock Hims & Hers (HIMS) spiked more than 24% in trading Thursday, days after its Super Bowl ad promoting cheaper ...

Weight-loss drugs helped Dimpy Kapoor shed 15 kg and reclaim her life. Ozempic and Mounjaro are a lifeline for diabetics and ...

Hims & Hers offers a copycat of the blockbuster weight-loss drug at a fraction of the cost. But it might be a short-lived ...

Columnist Teri Sforza writes that childhood obesity in California is on the rise, state data shows. Free school meals have ...

Lilly will provide an initial payment to complete a Phase I trial of OLX75016, which started in February 2024.

With the exception of "Editorial use only" photos (which can only be used in editorial projects and can't be modified), the possibilities are limitless. Learn more about royalty-free video footage or ...

A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name ...